Navigation Links
Vion Reports 2008 Third Quarter and Nine-Month Results
Date:11/3/2008

vo poor-risk acute myelogenous leukemia. Clinical trials of laromustine (Cloretazine(R), VNP40101M) with cytarabine in elderly patients with acute myelogenous leukemia, with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to file a New Drug Application or obtain regulatory approval for its products, particularly laromustine (Cloretazine,VNP40101M), delays in the regulatory approval process or delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not predictive of safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2007 and Form 10-Q for the quarter ended June 30, 2008. In particular, there can be no assurance
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008
2. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
3. NxStage Reports Third Quarter 2008 Financial Results
4. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
5. The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
6. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. Nuvelo Reports Third Quarter 2008 Financial Results
9. Claimsnet.com Reports Third Quarter 2008 Results
10. Remuda Ranch Reports Many Individuals With Eating Disorders Are Not Getting Help They Need
11. Palomar Medical Reports Financial Results for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 Foot and Ankle Specialists ... D. Palmer ( Annapolis and Clarksville Divisions ) ... at the Maryland Podiatric Medical Association meeting on April ... University in 1992 with a Bachelor of Arts in ... in intercollegiate soccer, track and cross-country. He then attended ...
(Date:4/27/2015)... 2015 Churchview Supportive Living, a Gardant ... Brunch and Fashion Show from 10:30 a.m. to noon ... at 2626 W. 63rd St. in Chicago, serves low-income ... help to maintain their independence. , “Mothers, grandmothers, godmothers ... Mother’s Day Brunch,” said Director of Marketing Elizabeth Clippard. ...
(Date:4/27/2015)... 28, 2015 Healthcare marketing specialists ... called “Website Anatomy 101.” Available for ... necessary design elements for a successful hospital website. ... design, user experience, search results and lead generation ... a well-designed website on patient volume and retention. ...
(Date:4/27/2015)... Tennessee (PRWEB) April 27, 2015 A variety ... help young people trapped in substance abuse. Programming for Jericho ... will serve girls, is launching this summer. , The first ... than $100,000 to serve adolescents. The Youth Town Jim Jackson ... Collierville on Monday, May 4, with tee times at 8 ...
(Date:4/27/2015)... 2015 "Understanding Mental Disorders: Your Guide ... by American Psychiatric Publishing, a division of the American ... at the National Press Club in Washington, D.C.. The ... by APA President Paul Summergrad, MD. Guest speakers will ... foreword to the book; Paul Gionfriddo, President and CEO ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives Maryland Podiatric Medical Association Outstanding Service Award 2Health News:Churchview Supportive Living Community in Chicago to Host Mother's Day Brunch 2Health News:Smith & Jones Publishes 2015 Website Design White Paper 2Health News:Golf, Sermon on the Mount and More to Support Youth Town’s Jericho and Eden Programs 2Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2
... popular Jonas Brothers band speaks about life with the condition, , ... was only 13, but on the cusp of living a life ... landed a recording contract and were touring from city to city ... suddenly lost a lot of weight -- about 15 pounds in ...
... COLUMBUS, Ga., Aug. 25 A f ... LATINA Style Top 50 company by LATINA Style ... report is distributed to Hispanic professional and civic organizations, national women,s organizations, ... House. LATINA Style surveyed more than 800 companies for this ...
... , , , ... II, Inc. today announced that its registration statement pertaining to an ... declared effective by the Securities and Exchange Commission on Aug. 24, ... REIT II intends to qualify as a publicly registered, non-traded real ...
... , , PHOENIX, Aug. ... communications systems, today announced that one of the largest university-based ... antenna solution and related satellite equipment to outfit its central ... the Simulsat broadcast system because of the antenna,s ability to ...
... babyUV/kidsUV inc. has released its newest line of sun protection swim wear ... older kids from 6-12 and comes in great new styles. The line ... to September 2 in booth 115. , , "This ... to protect their children from the harmful effects of the sun, and ...
... WILMINGTON, Delaware, August 25 According to a ... Device Technologies,Market (2009 - 2014), published by MarketsandMarkets,( ... top ten,medical device technologies is estimated to be ... alone constitute about 40%,of the entire market at ...
Cached Medicine News:Health News:Nick Jonas: Livin' the Dream Despite Diabetes 2Health News:Nick Jonas: Livin' the Dream Despite Diabetes 3Health News:Nick Jonas: Livin' the Dream Despite Diabetes 4Health News:LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 2Health News:LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 3Health News:Large National Cancer Research Center Selects ATCi's Simulsat C/Ku Broadcast System for Headquarters 2Health News:babyUV/kidsUV inc. Introduces Its kidsUV Surf Team Line of Sun Protection Swim Wear 2Health News:MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014 2Health News:MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014 3
(Date:4/27/2015)... , April 27, 2015 Harwood Feffer LLP ... board of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or ... board has breached its fiduciary duties to shareholders. ... press release announcing results from its first Phase 3 ... release disclosed that in the trial, Rhopressa failed to ...
(Date:4/27/2015)... Bronstein, Gewirtz & Grossman, LLC is investigating ... of Celladon Corporation ("Celladon" or the "Company") (NasdaqGM: CLDN ... Bronstein or his investor relations coordinator Eitan ... The investigation concerns whether Celladon and certain of ... 20(a) of the Securities Exchange Act of 1934.  ...
(Date:4/27/2015)... 2015  Eiger BioPharmaceuticals, Incorporated today announced the presentation ... in patients with chronic hepatitis delta viral (HDV) infection. ... at Ankara University Medical School, Turkey ... LOWR HDV - 1 (LOnafarnib With and ... randomized subjects to receive different doses of lonafarnib with ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celladon Corporation 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3
Straight shafts with rounded tips. Smooth handle with dull finish....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....
8 mm curved blade. Cutting edge on inside of curve. Flat handle....
... mm long blade. 17 mm ... mm, 12.0 inches. Note: Has ... left-hand cutting to any thickness ... mm). For thicker grafts or ...
Medicine Products: